Healing Reimagined
Immunicom’s Immunopheresis® is designed to empower
patients to best live their lives while receiving revolutionary
cancer treatment.This unique immunotherapy is intended
to meaningfully improve patients’ quality of life and
avoid typical side-effects.
LATEST MILESTONE
NCI/NIH Award $2 Million to Immunicom to Initiate Clinical Trial Evaluating Breakthrough Immunopheresis® LW-02 Molecular Subtractive Therapy in Refractory ER+/Her2- Breast Cancer

A transformative immunotherapy
Immunicom creates novel immunotherapies designed to treat a variety of diseases using Immunicom’s breakthrough Immunopheresis® technology platform.
The breakthrough Immunopheresis approach uses a therapeutic device that works outside of the body and is designed to treat cancer, inflammatory, renal, and autoimmune diseases by removing barriers from the blood that block the immune system from doing its job.
Our Recognition
Latest News
December 15, 2022
Longevity Technology – Innovative cancer treatment device has longevity potential
December 15, 2022
Oncology Tube: The LW-02 Cartridge
November 9, 2022
Empowered Patient Podcast with Karen Jagoda -Treating Tumors Using Subtractive Approach to Remove Molecules Suppressing Immune System with Amir Jafri Immunicom
June 14, 2022
NCI/NIH Award $2 Million to Immunicom to Initiate Clinical Trial Evaluating Breakthrough Immunopheresis® LW-02 Molecular Subtractive Therapy in Refractory ER+/Her2- Breast Cancer
Our Mission
To improve the quality of life for patients
in a meaningful way and expedite their
path to a healthy future.
Get in touch today
Let’s talk about what we can achieve together
Learn more about
our team
our team